atuzabrutinib structure
|
Common Name | atuzabrutinib | ||
|---|---|---|---|---|
| CAS Number | 1581714-49-9 | Molecular Weight | 539.60 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C30H30FN7O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of atuzabrutinibAtuzabrutinib is a potent BTK (Bruton's tyrosine kinase) inhibitor (patent WO2016100914A1)[1]. |
| Name | Atuzabrutinib |
|---|
| Description | Atuzabrutinib is a potent BTK (Bruton's tyrosine kinase) inhibitor (patent WO2016100914A1)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Steven GOURLAY, et al. Treatment of pemphigus. WO2016100914A1. |
| Molecular Formula | C30H30FN7O2 |
|---|---|
| Molecular Weight | 539.60 |
| InChIKey | KZMQPYCXSAGLTB-ZWUNQBBJSA-N |
| SMILES | CC(C)(C)C=C(C#N)C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1 |